Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Kilitch Drugs (India) Limited (NSE: KILITCH), ISIN INE729D01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
KILITCH last traded at ₹198.10 (+1.46%), with a 52-week range of ₹117.25 to ₹267.90 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 63.77%, FIIs 0.10%, DIIs 0.50%, mutual funds 0.00%.
EquiSense Score (ECS): 54/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.